These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22766509)

  • 21. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors.
    Tontonoz P
    Cold Spring Harb Symp Quant Biol; 2011; 76():129-37. PubMed ID: 21859674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases.
    Faulds MH; Zhao C; Dahlman-Wright K
    Curr Opin Pharmacol; 2010 Dec; 10(6):692-7. PubMed ID: 20829110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of prostaglandin F2α against β amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia.
    Zhuang J; Zhang H; Zhou R; Chen L; Chen J; Shen X
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():45-52. PubMed ID: 24076168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
    Xiao L; Xie X; Zhai Y
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages.
    Marino JP; Kallander LS; Ma C; Oh HJ; Lee D; Gaitanopoulos DE; Krawiec JA; Parks DJ; Webb CL; Ziegler K; Jaye M; Thompson SK
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5617-21. PubMed ID: 19717304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux.
    Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE and cholesterol homeostasis in Alzheimer's disease.
    Leduc V; Jasmin-Bélanger S; Poirier J
    Trends Mol Med; 2010 Oct; 16(10):469-77. PubMed ID: 20817608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis.
    Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson JÅ; Korach-André M
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E494-502. PubMed ID: 24368671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.
    Bovenga F; Sabbà C; Moschetta A
    Cell Metab; 2015 Apr; 21(4):517-26. PubMed ID: 25863245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages.
    Töröcsik D; Szanto A; Nagy L
    Mol Aspects Med; 2009 Jun; 30(3):134-52. PubMed ID: 19248804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin induces ABCA1 expression and apolipoprotein A-I-mediated cholesterol transmembrane in the chronic cerebral hypoperfusion aging rats.
    Tian M; Zhang X; Wang L; Li Y
    Am J Chin Med; 2013; 41(5):1027-42. PubMed ID: 24117066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MyD88 acts as an adaptor protein for inflammatory signalling induced by amyloid-β in macrophages.
    O'Halloran S; O'Leary A; Kuijper T; Downer EJ
    Immunol Lett; 2014 Nov; 162(1 Pt A):109-18. PubMed ID: 25124962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
    Cai Z; Hussain MD; Yan LJ
    Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid-activated nuclear receptors and sepsis.
    de Lima-Salgado TM; Cruz LM; Souza HP
    Endocr Metab Immune Disord Drug Targets; 2010 Sep; 10(3):258-65. PubMed ID: 20509837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of metabolism and inflammation by lipid-activated nuclear receptors.
    Bensinger SJ; Tontonoz P
    Nature; 2008 Jul; 454(7203):470-7. PubMed ID: 18650918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver X receptor: from metabolism to cancer.
    Venteclef N; Ferré P
    Biochem J; 2014 Apr; 459(2):e1-3. PubMed ID: 24678940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver X receptor: a cardinal target for atherosclerosis and beyond.
    Parikh M; Patel K; Soni S; Gandhi T
    J Atheroscler Thromb; 2014; 21(6):519-31. PubMed ID: 24695022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feeding probiotic Lactobacillus paracasei to Ossabaw pigs on a high-fat diet prevents cholesteryl-ester accumulation and LPS modulation of the Liver X receptor and inflammatory axis in alveolar macrophages.
    Trasino SE; Dawson HD; Urban JF; Wang TT; Solano-Aguilar G
    J Nutr Biochem; 2013 Nov; 24(11):1931-9. PubMed ID: 24060267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The link between altered cholesterol metabolism and Alzheimer's disease.
    Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
    Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.